HCV RNA-dependent RNA polymerase as a target for antiviral development.
about
Dynamics of Subgenomic Hepatitis C Virus Replicon RNA Levels in Huh-7 Cells after Exposure to Nucleoside AntimetabolitesMolecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796Promising candidates for the treatment of chronic hepatitis C.Molecular simulations illuminate the role of regulatory components of the RNA polymerase from the hepatitis C virus in influencing protein structure and dynamicsPost-transcriptional inhibition of hepatitis C virus replication through small interference RNA.Hepatitis C virus therapies: current treatments, targets and future perspectives.Allosteric inhibitors have distinct effects, but also common modes of action, in the HCV polymerase.New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote inPharmacokinetics, safety, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor for hepatitis C virus, following single ascending doses in healthy subjects.The R protein of SARS-CoV: analyses of structure and function based on four complete genome sequences of isolates BJ01-BJ04Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication.Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.Influence of genome-scale RNA structure disruption on the replication of murine norovirus--similar replication kinetics in cell culture but attenuation of viral fitness in vivo.HCV genetics and genotypes dictate future antiviral strategies.HCV NS3/4A Protease Inhibitors and the Road to Effective Direct-Acting Antiviral Therapies
P2860
Q27485663-197F0576-2C5C-4779-AA23-8D5196773627Q27486816-790C44A5-2791-4A52-9688-8990F2D4C6E8Q30333233-0047F6EC-ECB9-460E-AD6D-D999327F730CQ30431492-74144D05-3025-4A4A-8458-790A55B59548Q34911559-EC0D90CD-1F7B-4918-97B0-4778682FEC64Q35147050-0E9B7BF9-B0CF-4DB5-9C60-572DA0964C9BQ35333600-483229F3-B106-47CE-BF6F-4FBB7F91B241Q35653358-DCA2AE6E-3B9E-47D8-A01C-D61C58EF7BBCQ36329145-5DF719C6-FFDD-4019-BE53-22EFE4417E4CQ36667039-0D5CB186-A144-4852-9030-59B811404380Q37519394-20DF6C79-3D64-4C98-B597-13312FBA80F8Q40220112-BC10031D-3A91-4D49-8B7B-FBD0F3F33EDCQ40604363-463C0834-AF35-47BC-8006-B3EE00868D0DQ41516919-B2623726-BF2E-474F-913F-F95758685FA7Q47547339-DC8F7741-440E-4A52-A9E2-A0E83742F130Q57168365-ED256181-5D7E-44A1-85F1-1790AF006CCC
P2860
HCV RNA-dependent RNA polymerase as a target for antiviral development.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@ast
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@en
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@nl
type
label
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@ast
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@en
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@nl
prefLabel
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@ast
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@en
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@nl
P1476
HCV RNA-dependent RNA polymerase as a target for antiviral development.
@en
P2093
Michelle P Walker
P304
P356
10.1016/S1471-4892(02)00195-9
P577
2002-10-01T00:00:00Z